Ibaraki, Japan

Teruko Ariyama




Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Teruko Ariyama: Innovator in Pharmaceutical Preparations

Introduction

Teruko Ariyama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative tablet and solution-type preparations. With a total of 2 patents, his work has had a meaningful impact on medication formulation.

Latest Patents

Ariyama's latest patents include a stable tablet containing droxidopa and a solubilization preparation of lurasidone. The stable tablet is characterized by containing droxidopa as an active ingredient in a proportion of 20-80 wt % relative to the total weight of the tablet. It also includes at least one excipient selected from mannitol, lactose, erythritol, glucose, sucrose, crystalline cellulose, and corn-derived starch. Additionally, the solubilization preparation comprises lurasidone as an active ingredient and contains substances such as benzyl alcohol, N,N-dimethylacetamide, lactic acid, and propylene glycol.

Career Highlights

Throughout his career, Ariyama has worked with prominent companies in the pharmaceutical industry, including Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical technologies.

Collaborations

Ariyama has collaborated with notable coworkers, including Kazuya Otoda and Mayumi Nakamura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Teruko Ariyama's contributions to pharmaceutical preparations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of medication formulation, and his collaborations with industry professionals further enhance his impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…